Greenwich LifeSciences, Inc. GLSI
Set alert
17.41 USD -1.59 -8.37%
At close
17.44 +0.03 +0.17%
Pre-market · Nov 2, 7:03 AM ET
17.08 Day range 18.77
7.78 52-week range 34.10
- YTD
- -17.13%
- 1 year
- +89.45%
- Open
- 18.47
- Prev close
- 19.00
- Mkt cap
- 255.55M
- Vol
- 174.65K
- Avg vol
- 127.98K
- EPS
- -1.53
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 17.08
- High
- 18.77
- Forward P/E
- -14.83
- Beta
- 3.32
- Short ratio
- 21.41
- Inst. own
- 8.70%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 14, 2024
- 50-d avg
- 13.57
- 200-d avg
- 14.65
- 1y target
- 38.00
2Y chart
Events in this range
- Nov 14, 2024Earnings: -0.2; estimate -0.21; surprise 4.76%
Signals (105)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 26, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 26, 2026 | 6 days ago |
| SMA: Bearish | Oct 13, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 2, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 15, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 1, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
| SMA: Bullish | Aug 25, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| RSI: Oversold | Jul 29, 2026 | 3 months ago |
| RSI: Oversold | Jul 22, 2026 | 3 months ago |
| RSI: Oversold | Jul 20, 2026 | 3 months ago |
| SMA: Bearish | Jul 7, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 6, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 1, 2026 | 4 months ago |
| SMA: Bullish | Jun 26, 2026 | 4 months ago |
| SMA: Bearish | Jun 25, 2026 | 4 months ago |
| SMA: Bearish | Jun 2, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| SMA: Bullish | May 13, 2026 | 5 months ago |
| MACD: Buy Signal | May 11, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 23, 2026 | 6 months ago |
| SMA: Bearish | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 9, 2026 | 6 months ago |
| MACD: Sell Signal | Mar 20, 2026 | 7 months ago |
| SMA: Bearish | Mar 19, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Feb 24, 2026 | 8 months ago |
| SMA: Bearish | Feb 23, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 3, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 27, 2026 | 9 months ago |
| RSI: Overbought | Jan 27, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 20, 2026 | 9 months ago |
| RSI: Overbought | Jan 12, 2026 | 9 months ago |
| RSI: Overbought | Jan 7, 2026 | 9 months ago |
| RSI: Overbought | Jan 5, 2026 | 10 months ago |
| RSI: Overbought | Dec 18, 2025 | 10 months ago |
| SMA: Bullish | Dec 11, 2025 | 10 months ago |
| RSI: Overbought | Dec 11, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 14, 2025 | 11 months ago |
| RSI: Oversold | Nov 4, 2025 | 12 months ago |
| MACD: Sell Signal | Oct 14, 2025 | 1 year ago |
| SMA: Bearish | Oct 10, 2025 | 1 year ago |
| SMA: Bearish | Oct 9, 2025 | 1 year ago |
| SMA: Bullish | Oct 8, 2025 | 1 year ago |
| SMA: Bullish | Oct 6, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 6, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| SMA: Bearish | Sep 23, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 23, 2025 | 1 year ago |
| SMA: Bullish | Sep 22, 2025 | 1 year ago |
| SMA: Bearish | Sep 19, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 19, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bullish | Sep 18, 2025 | 1 year ago |
| SMA: Bearish | Sep 17, 2025 | 1 year ago |
| SMA: Bearish | Sep 16, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Sep 15, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 10, 2025 | 1 year ago |
| SMA: Bullish | Sep 10, 2025 | 1 year ago |
| SMA: Bearish | Sep 4, 2025 | 1 year ago |
| SMA: Bearish | Sep 4, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 14, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 8, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 7, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 6, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 29, 2025 | 1 year ago |
| RSI: Overbought | Jul 17, 2025 | 1 year ago |
| RSI: Overbought | Jul 9, 2025 | 1 year ago |
| SMA: Bullish | Jul 2, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 1, 2025 | 1 year ago |
| SMA: Bearish | Jun 12, 2025 | 1 year ago |
| SMA: Bullish | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 3, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 29, 2025 | 1 year ago |
| SMA: Bearish | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 17, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 16, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 11, 2025 | 1 year ago |
| RSI: Oversold | Mar 28, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 20, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 6, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 6, 2025 | 1 year ago |
| SMA: Bearish | Feb 4, 2025 | 1 year ago |
| SMA: Bullish | Feb 3, 2025 | 1 year ago |
| SMA: Bearish | Jan 31, 2025 | 1 year ago |
| SMA: Bullish | Jan 24, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 6, 2025 | 1 year ago |
| RSI: Oversold | Dec 30, 2024 | 1 year ago |
Key statistics
- Market cap
- 159.84M
- Enterprise value
- 171.41M
- Trailing P/E
- 0.00
- Forward P/E
- -14.83
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 23.30
- EPS (TTM)
- -0.81
- Beta
- 3.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -3.15M
- Total cash
- 7.22M
- Total debt
- 0
- Return on equity
- -123.67%
- Shares outstanding
- 13.14M
- Short % of float
- 7.83%
- 50-day average
- 13.57
- 200-day average
- 14.65
Analyst view
Consensus: none
Price target (mean) 38.00
Next earnings
Aug 14, 2024
Expected Aug 14, 2024. Consensus EPS estimate 0.00.
Financials — quick view
GLSI Revenue — quarterly 0
GLSI Net income — quarterly -3.95M
GLSI EPS — quarterly -0.27
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 14, 2024 | Sep 1, 2024 | -0.21 | -0.20 | +0.01 | +4.76% |
| Aug 14, 2024 | Jun 1, 2024 | -0.20 | -0.20 | 0.00 | 0.00% |
| Aug 14, 2024 | Jun 1, 2024 | -0.20 | — | — | — |
| May 20, 2024 | Mar 1, 2024 | -0.20 | -0.19 | +0.01 | +5.00% |
| May 20, 2024 | Mar 1, 2024 | -0.20 | — | — | — |
| Apr 15, 2024 | Dec 1, 2023 | 0.00 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 23, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| May 22, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Feb 28, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Feb 20, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Apr 10, 2023 | HC Wainwright & Co. | reit | — | Buy |
| Sep 1, 2021 | HC Wainwright & Co. | init | — | Buy |
About Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- greenwichlifesciences.com
News
- Greenwich LifeSciences Extends 100% Insider Share Lock‑Up To January 31, 2027
- HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $69
- Greenwich LifeSciences Expects Q2 Cash Burn To Be ~$2M, Down From $4.7M In Q1, With Cash Balance Of ~$8.9M As Of June And Expected Burn Rate Of $2-4M Per Quarter Going Forward
- Greenwich LifeSciences Receives Approval From European Medicines Agency To Combine HLA-A*02, Non-HLA-A*02 Participants In Europe
- Greenwich LifeSciences Receives EMA Approval To Use Commercially Manufactured GP2 In Its FLAMINGO-01 Phase III Clinical Trial
- Greenwich LifeSciences Q4 EPS $(0.58) Misses $(0.31) Estimate
- Greenwich LifeSciences Announces Published Abstract And Poster On Its Phase III FLAMINGO-01 Trial For GLSI-100 To Prevent Breast Cancer Recurrences From The ASCO Annual Meeting 2026
- Greenwich LifeSciences Reports Progress in Late-Stage Breast Cancer Immunotherapy Trial
- Greenwich LifeSciences Receives Nasdaq Noncompliance Notice
- Why Kyverna Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on GLSI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| PATEL SNEHAL | Chief Executive Officer | Purchase | Sep 25, 2024 | 5,536,100 |
| THOMPSON JAYE L | Officer | Purchase | Nov 20, 2024 | 264,148 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 2.66% | 350,144 | 4.26M | Sep 29, 2024 |
| Vanguard Group Inc | 2.08% | 273,525 | 3.33M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.02% | 133,550 | 1.62M | Sep 29, 2024 |
| Credit Agricole S.A. | 0.66% | 87,000 | 1.06M | Sep 29, 2024 |
| Northern Trust Corporation | 0.57% | 74,500 | 905.92K | Sep 29, 2024 |
| State Street Corporation | 0.54% | 71,408 | 868.32K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.17% | 153,459 | 1.87M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.08% | 141,696 | 1.72M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.54% | 71,311 | 867.14K | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.47% | 61,696 | 750.22K | Aug 30, 2024 |
| iShares Russell 2000 Growth ETF | 0.39% | 50,661 | 616.04K | Oct 30, 2024 |
| Fidelity Extended Market Index Fund | 0.25% | 32,217 | 391.76K | Oct 30, 2024 |